NCT07053254 The Characteristics and Treatment Mechanism of Vascular Grafts in Elderly Patients With CAOD Through Single-cell Transcriptome Analysis
| NCT ID | NCT07053254 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yonsei University |
| Condition | Coronary Artery Occlusive Disease (CAOD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-04-12 |
| Primary Completion | 2027-04-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-04-12 with a primary completion date of 2027-04-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to establish a cardiovascular biobank using vascular grafts obtained from participants with coronary artery occlusive disease (CAOD). Through genomic and transcriptomic analyses, the study seeks to characterize the biological features of the vascular grafts and identify potential therapeutic targets and mechanisms related to vascular remodeling and stiffness.
Eligibility Criteria
Inclusion Criteria: * Adults aged 19 years or older, Patients scheduled to undergo coronary artery bypass grafting (CABG), Patients who voluntarily provide written informed consent for study participation, Patients who are able and willing to comply with study procedures during the study period Exclusion Criteria: * Pediatric or adolescent patients under 18 years of age, Patients requiring concomitant surgical correction for valvular heart disease, Patients undergoing reoperative (redo) cardiac surgery, Patients who decline to provide informed consent prior to surgery
Frequently Asked Questions
Who can join the NCT07053254 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 100 Years, studying Coronary Artery Occlusive Disease (CAOD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07053254 currently recruiting?
Yes, NCT07053254 is actively recruiting participants. Visit ClinicalTrials.gov or contact Yonsei University to inquire about joining.
Where is the NCT07053254 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT07053254 clinical trial?
NCT07053254 is sponsored by Yonsei University. The trial plans to enroll 100 participants.